Back in January, Moderna set a planned mpox vaccine on the back burner as the immediate outbreak waned, but now the shot has slid into the priority lane, with entry to the clinic likely a “month or so ...

A Moderna influenza vaccine for avian influenza, or “bird flu,” will head into a pivotal clinical trial with $176 million in funding from the U.S. federal government. The funding announced by Moderna ...

Moderna is eyeing testing two vaccine candidates, one for mpox and another for bird flu, in humans later this year, Bloomberg reported March 6. The drugmaker’s president, Stephen Hoge, MD, said ...

The first mRNA mpox vaccine to be pitted against licensed vaccines beat its rivals by easing symptoms and potentially cutting transmission, according to new research published Tuesday, a coup for ...

Moderna revealed Wednesday that its flu vaccine using mRNA technology has offered promising results as the flu season begins to ramp up. Moderna announced that its seasonal flu vaccine “demonstrated ...

Moderna and Merck’s new mRNA vaccine reduces the chance of relapse or death of skin cancer by half when paired with Merck’s immunotherapy drug Keytruda, new data shows, marking a step forward in the ...

Moderna has become a well-known name thanks to its highly effective COVID-19 vaccine, based on mRNA technology. But even before the pandemic hit, the company was developing an mRNA-based vaccine ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID shot. The question is whether it gets approved for both viruses. Why it ...

Vaccine makers Pfizer and Moderna are trying to get out ahead of some of the new coronavirus variants that are causing concern around the world. Although there's no evidence people immunized with ...

Fall season is also flu season, and it's a time when people are accustomed to receiving their annual shots. This year it will also serve as the first big test of demand for COVID shots. COVID vaccine ...

Children under 5 in the U.S. aren’t yet eligible for a Covid-19 vaccine, after setbacks have slowed efforts to get the shots to market. WSJ’s Peter Loftus explains what we know about the vaccines and ...